Brain microglia express steroid-converting enzymes in the mouse

Journal of Steroid Biochemistry and Molecular Biology

Volumn 109, Issue 1-2, 2008, Pages 96-107

  Gottfried Blackmore, Andres ^a   Sierra, Amanda ^a   Jellinck, Peter H ^b   McEwen, Bruce S ^a   Bulloch, Karen ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b QUEEN S UNIVERSITY   (Canada)

Author keywords

Adiol; Cytokines; DHEA; Estrogen; LPS; Neurosteroids; PBR; Steroidogenesis

Indexed keywords

ANDROGEN; ANDROSTANEDIOL; ESTROGEN; MESSENGER RNA; PRASTERONE; STEROID 5ALPHA REDUCTASE 1; TESTOSTERONE 17BETA DEHYDROGENASE; TUMOR NECROSIS FACTOR ALPHA;

ANDROGEN METABOLISM; ANIMAL CELL; ARTICLE; BRAIN CELL; CELL CULTURE; CONTROLLED STUDY; ESTROGEN METABOLISM; IMMUNOMODULATION; MICROENVIRONMENT; MICROGLIA; MOUSE; NERVE CELL; NERVE DEGENERATION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION;

17-HYDROXYSTEROID DEHYDROGENASES; ANDROSTENEDIOL; ANIMALS; BASE SEQUENCE; BRAIN; DNA PRIMERS; GENE EXPRESSION; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, TRANSGENIC; MICROGLIA; RECEPTORS, ESTROGEN; RECEPTORS, GABA; RNA, MESSENGER; STEROIDS; TESTOSTERONE 5-ALPHA-REDUCTASE;

EID: 40849111137     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2007.12.013     Document Type: Article

References (86)

1. Bryant D.N., et al. Multiple pathways transmit neuroprotective effects of gonadal steroids. Endocrine 29 2 (2006) 199-207
2. Cooke B.M., and Woolley C.S. Gonadal hormone modulation of dendrites in the mammalian CNS. J. Neurobiol. 64 1 (2005) 34-46
3. Garcia-Ovejero D., et al. Glia-neuron crosstalk in the neuroprotective mechanisms of sex steroid hormones. Brain Res. Brain Res. Rev. 48 2 (2005) 273-286
4. Krause D.N., Duckles S.P., and Pelligrino D.A. Influence of sex steroid hormones on cerebrovascular function. J. Appl. Physiol. 101 4 (2006) 1252-1261
5. Scharfman H.E., and MacLusky N.J. The influence of gonadal hormones on neuronal excitability, seizures, and epilepsy in the female. Epilepsia 47 9 (2006) 1423-1440
6. McEwen B. Estrogen actions throughout the brain. Recent Prog. Horm. Res. 57 (2002) 357-384
7. Galea L.A., et al. Gonadal hormone modulation of hippocampal neurogenesis in the adult. Hippocampus 16 3 (2006) 225-232
8. Endoh A., et al. The zona reticularis is the site of biosynthesis of dehydroepiandrosterone and dehydroepiandrosterone sulfate in the adult human adrenal cortex resulting from its low expression of 3 beta-hydroxysteroid dehydrogenase. J. Clin. Endocrinol. Metab. 81 10 (1996) 3558-3565
9. Mason J.I., Bird I.M., and Rainey W.E. Adrenal androgen biosynthesis with special attention to P450c17. Ann. NY Acad. Sci. 774 (1995) 47-58
10. Turgeon J.L., et al. Complex actions of sex steroids in adipose tissue, the cardiovascular system, and brain: insights from basic science and clinical studies. Endocr. Rev. 27 6 (2006) 575-605
11. Baulieu E.E. Neurosteroids: of the nervous system, by the nervous system, for the nervous system. Recent Prog. Horm. Res. 52 (1997) 1-32
12. Schumacher M., et al. Neurosteroids in the hippocampus: neuronal plasticity and memory. Stress 2 1 (1997) 65-78
13. Paul S.M., and Purdy R.H. Neuroactive steroids. Faseb J. 6 6 (1992) 2311-2322
14. Majewska M.D. Neurosteroids: endogenous bimodal modulators of the GABAA receptor. Mechanism of action and physiological significance. Prog. Neurobiol. 38 4 (1992) 379-395
15. Tsutsui K. Biosynthesis and organizing action of neurosteroids in the developing Purkinje cell. Cerebellum 5 2 (2006) 89-96
16. Schumacher M., et al. Local synthesis and dual actions of progesterone in the nervous system: neuroprotection and myelination. Growth Horm. IGF Res. 14 Suppl. A (2004) S18-S33
17. Azcoitia I., et al. Brain aromatase is neuroprotective. J. Neurobiol. 47 4 (2001) 318-329
18. Zwain I.H., and Yen S.S. Neurosteroidogenesis in astrocytes, oligodendrocytes, and neurons of cerebral cortex of rat brain. Endocrinology 140 8 (1999) 3843-3852
19. Aloisi F. Immune function of microglia. Glia 36 2 (2001) 165-179
20. Griffin W.S. Inflammation and neurodegenerative diseases. Am. J. Clin. Nutr. 83 2 (2006) 470S-474S
21. Kim Y.S., and Joh T.H. Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson's disease. Exp. Mol. Med. 38 4 (2006) 333-347
22. Raivich G., and Banati R. Brain microglia and blood-derived macrophages: molecular profiles and functional roles in multiple sclerosis and animal models of autoimmune demyelinating disease. Brain Res. Brain Res. Rev. 46 3 (2004) 261-281
23. Schumacher M., et al. Steroid hormones and neurosteroids in normal and pathological aging of the nervous system. Prog. Neurobiol. 71 1 (2003) 3-29
24. Straub R.H., et al. Serum dehydroepiandrosterone (DHEA) and DHEA sulfate are negatively correlated with serum interleukin-6 (IL-6), and DHEA inhibits IL-6 secretion from mononuclear cells in man in vitro: possible link between endocrinosenescence and immunosenescence. J. Clin. Endocrinol. Metab. 83 6 (1998) 2012-2017
25. Cutolo M., et al. Sex hormone modulation of cell growth and apoptosis of the human monocytic/macrophage cell line. Arthritis Res. Ther. 7 5 (2005) R1124-R1132
26. Jacobson J.D., and Ansari M.A. Immunomodulatory actions of gonadal steroids may be mediated by gonadotropin-releasing hormone. Endocrinology 145 1 (2004) 330-336
27. Schmidt M., et al. Inflammation and sex hormone metabolism. Ann. NY Acad. Sci. 1069 (2006) 236-246
28. Jellinck P.H., et al. Metabolism of dehydroepiandrosterone by rodent brain cell lines: relationship between 7-hydroxylation and aromatization. J. Steroid Biochem. Mol. Biol. 93 1 (2005) 81-86
29. Jellinck P.H., et al. Dehydroepiandrosterone (DHEA) metabolism in the brain: identification by liquid chromatography/mass spectrometry of the delta-4-isomer of DHEA and related steroids formed from androstenedione by mouse BV2 microglia. J. Steroid Biochem. Mol. Biol. 98 1 (2006) 41-47
30. Jellinck P.H., Kaufmann M., Gottfried-Blackmore A., McEwen B.S., Jones G., and Bulloch K. Selective conversion by microglia of dehydroepiandrosterone to 5-androstenediol-a steroid with inherent estrogenic properties. J. Steroid Biochem. Mol. Biol. 107 3-5 (2007) 156-162
31. Bessis A., et al. Microglial control of neuronal death and synaptic properties. Glia 55 3 (2007) 233-238
32. Raivich G. Like cops on the beat: the active role of resting microglia. Trends Neurosci. 28 11 (2005) 571-573
33. Sasmono R.T., et al. A macrophage colony-stimulating factor receptor-green fluorescent protein transgene is expressed throughout the mononuclear phagocyte system of the mouse. Blood 101 3 (2003) 1155-1163
34. Sierra A., et al. Microglia derived from aging mice exhibit an altered inflammatory profile. Glia 55 4 (2007) 412-424
35. Rivest S. Molecular insights on the cerebral innate immune system. Brain Behav. Immun. 17 1 (2003) 13-19
36. Casellas P., Galiegue S., and Basile A.S. Peripheral benzodiazepine receptors and mitochondrial function. Neurochem. Int. 40 6 (2002) 475-486
37. Poortman J., et al. Interaction of delta-5-androstene-3beta, 17beta-diol with estradiol and dihydrotestosterone receptors in human myometrial and mammary cancer tissue. J. Clin. Endocrinol. Metab. 40 3 (1975) 373-379
38. Stein D.G., Hoffman S.W., and Estrogen. progesterone as neuroprotective agents in the treatment of acute brain injuries. Pediatr. Rehabil. 6 1 (2003) 13-22
39. Wise P.M., et al. Estradiol is a neuroprotective factor in in vivo and in vitro models of brain injury. J Neurocytol 29 5-6 (2000) 401-410
40. Azcoitia I., et al. Brain steroidogenesis: emerging therapeutic strategies to prevent neurodegeneration. J. Neural Transm. 112 1 (2005) 171-176
41. Zwain I.H., and Yen S.S. Dehydroepiandrosterone: biosynthesis and metabolism in the brain. Endocrinology 140 2 (1999) 880-887
42. Baulieu E.E., and Robel P. Dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) as neuroactive neurosteroids. Proc. Natl. Acad. Sci. U.S.A. 95 8 (1998) 4089-4091
43. Sierra A. Neurosteroids: the StAR protein in the brain. J. Neuroendocrinol. 16 9 (2004) 787-793
44. Stocco D.M. The role of the StAR protein in steroidogenesis: challenges for the future. J. Endocrinol. 164 3 (2000) 247-253
45. Rodriguez-Agudo D., et al. Localization of StarD5 cholesterol binding protein. J. Lipid Res. 47 6 (2006) 1168-1175
46. Hauet T., et al. PBR, StAR, and PKA: partners in cholesterol transport in steroidogenic cells. Endocr. Res. 28 4 (2002) 395-401
47. Lacor P., et al. Regulation of the expression of peripheral benzodiazepine receptors and their endogenous ligands during rat sciatic nerve degeneration and regeneration: a role for PBR in neurosteroidogenesis. Brain Res. 815 1 (1999) 70-80
48. Brown R.C., and Papadopoulos V. Role of the peripheral-type benzodiazepine receptor in adrenal and brain steroidogenesis. Int. Rev. Neurobiol. 46 (2001) 117-143
49. Decaudin D. Peripheral benzodiazepine receptor and its clinical targeting. Anticancer Drugs 15 8 (2004) 737-745
50. Galiegue S., Tinel N., and Casellas P. The peripheral benzodiazepine receptor: a promising therapeutic drug target. Curr. Med. Chem. 10 16 (2003) 1563-1572
51. Papadopoulos V., et al. Peripheral-type benzodiazepine receptor in neurosteroid biosynthesis, neuropathology and neurological disorders. Neuroscience 138 3 (2006) 749-756
52. Carayon P., et al. Involvement of peripheral benzodiazepine receptors in the protection of hematopoietic cells against oxygen radical damage. Blood 87 8 (1996) 3170-3178
53. Banati R.B. Visualising microglial activation in vivo. Glia 40 2 (2002) 206-217
54. Taupin V., et al. Modulation of tumor necrosis factor-alpha, interleukin-1 beta, interleukin-6, interleukin-8, and granulocyte/macrophage colony-stimulating factor expression in human monocytes by an endogenous anxiogenic benzodiazepine ligand, triakontatetraneuropeptide: evidence for a role of prostaglandins. Mol. Pharmacol. 43 1 (1993) 64-69
55. Taupin V., et al. Increase in IL-6, IL-1 and TNF levels in rat brain following traumatic lesion. Influence of pre- and post-traumatic treatment with Ro5-4864, a peripheral-type (p site) benzodiazepine ligand. J. Neuroimmunol. 42 2 (1993) 177-185
56. i responses in human microglia by the peripheral benzodiazepine receptor ligand PK11195. J. Neurochem. 83 3 (2002) 546-555
57. Leonelli E., et al. Ro5-4864, a synthetic ligand of peripheral benzodiazepine receptor, reduces aging-associated myelin degeneration in the sciatic nerve of male rats. Mech. Ageing Dev. 126 11 (2005) 1159-1163
58. Veiga S., Azcoitia I., and Garcia-Segura L.M. Ro5-4864, a peripheral benzodiazepine receptor ligand, reduces reactive gliosis and protects hippocampal hilar neurons from kainic acid excitotoxicity. J. Neurosci. Res. 80 1 (2005) 129-137
59. Chensue S.W., et al. In vivo biologic and immunohistochemical analysis of interleukin-1 alpha, beta and tumor necrosis factor during experimental endotoxemia. Kinetics, Kupffer cell expression, and glucocorticoid effects. Am. J. Pathol. 138 2 (1991) 395-402
60. Besedovsky H.O., and del Rey A. Immune-neuro-endocrine interactions: facts and hypotheses. Endocr. Rev. 17 1 (1996) 64-102
61. Badrinarayanan R., et al. Corticosterone impairs the mRNA expression and activity of 3beta- and 17beta-hydroxysteroid dehydrogenases in adult rat Leydig cells. Biochem. Cell. Biol. 84 5 (2006) 745-754
62. Gao H.B., et al. Suppression of endogenous corticosterone levels in vivo increases the steroidogenic capacity of purified rat Leydig cells in vitro. Endocrinology 137 5 (1996) 1714-1718
63. Agarwal A.K., and Auchus R.J. Minireview: cellular redox state regulates hydroxysteroid dehydrogenase activity and intracellular hormone potency. Endocrinology 146 6 (2005) 2531-2538
64. Andreani C.L., et al. Cytokine-mediated regulation of ovarian function. Tumor necrosis factor alpha inhibits gonadotropin-supported ovarian androgen biosynthesis. J. Biol. Chem. 266 11 (1991) 6761-6766
65. Xiong Y., and Hales D.B. Differential effects of tumor necrosis factor-alpha and interleukin-1 on 3 beta-hydroxysteroid dehydrogenase/delta 5 → delta 4 isomerase expression in mouse Leydig cells. Endocrine 7 3 (1997) 295-301
66. Hurwitz A., et al. Cytokine-mediated regulation of ovarian function: interleukin-1 inhibits gonadotropin-induced androgen biosynthesis. Endocrinology 129 3 (1991) 1250-1256
67. Pomerantz D.K., and Pitelka V. Nitric oxide is a mediator of the inhibitory effect of activated macrophages on production of androgen by the Leydig cell of the mouse. Endocrinology 139 3 (1998) 922-931
68. Hales D.B. Interleukin-1 inhibits Leydig cell steroidogenesis primarily by decreasing 17 alpha-hydroxylase/C17-20 lyase cytochrome P450 expression. Endocrinology 131 5 (1992) 2165-2172
69. Li X., et al. Tumor necrosis factor-alpha inhibition of 17 alpha-hydroxylase/C17-20 lyase gene (Cyp17) expression. Endocrinology 136 8 (1995) 3519-3526
70. Onami S., et al. Splenic macrophages can modify steroidogenesis of Leydig cells. Endocr. J. 43 5 (1996) 477-485
71. Milewich L., Kaimal V., and Toews G.B. Androstenedione metabolism in human alveolar macrophages. J. Clin. Endocrinol. Metab. 56 5 (1983) 920-924
72. Kemppainen J.A., et al. Distinguishing androgen receptor agonists and antagonists: distinct mechanisms of activation by medroxyprogesterone acetate and dihydrotestosterone. Mol. Endocrinol. 13 3 (1999) 440-454
73. Jakob F., et al. Expression and regulation of aromatase cytochrome P450 in THP 1 human myeloid leukaemia cells. Mol. Cell Endocrinol. 110 1-2 (1995) 27-33
74. Schmidt M., et al. Conversion of dehydroepiandrosterone to downstream steroid hormones in macrophages. J. Endocrinol. 164 2 (2000) 161-169
75. Majewska M.D. Neuronal actions of dehydroepiandrosterone. Possible roles in brain development, aging, memory, and affect. Ann. NY Acad. Sci. 774 (1995) 111-120
76. Regelson W., and Kalimi M. Dehydroepiandrosterone (DHEA)-the multifunctional steroid. II. Effects on the CNS, cell proliferation, metabolic and vascular, clinical and other effects. Mechanism of action?. Ann. NY Acad. Sci. 719 (1994) 564-575
77. Weill-Engerer S., et al. Neurosteroid quantification in human brain regions: comparison between Alzheimer's and nondemented patients. J. Clin. Endocrinol. Metab. 87 11 (2002) 5138-5143
78. Weill-Engerer S., et al. In vitro metabolism of dehydroepiandrosterone (DHEA) to 7alpha-hydroxy-DHEA and Delta5-androstene-3beta,17beta-diol in specific regions of the aging brain from Alzheimer's and non-demented patients. Brain Res. 969 1-2 (2003) 117-125
79. Adams J.B. Control of secretion and the function of C19-delta 5-steroids of the human adrenal gland. Mol. Cell Endocrinol. 41 1 (1985) 1-17
80. Miyamoto H., et al. Delta5-androstenediol is a natural hormone with androgenic activity in human prostate cancer cells. Proc. Natl. Acad. Sci. U.S.A. 95 19 (1998) 11083-11088
81. Thieulant M.L., et al. Binding and effects of 5 alpha-androstane-3 beta, 17 beta-diol in the male rat pituitary. J. Steroid Biochem. 19 1A (1983) 241-246
82. Baulieu E.E., and Robel P. Dehydroepiandrosterone and dehydroepiandrosterone sulfate as neuroactive neurosteroids. J. Endocrinol. 150 Suppl. (1996) S221-S239
83. Weidler C., et al. Tumor necrosis factor inhibits conversion of dehydroepiandrosterone sulfate (DHEAS) to DHEA in rheumatoid arthritis synovial cells: a prerequisite for local androgen deficiency. Arthritis Rheum. 52 6 (2005) 1721-1729
84. Hennebold J.D., and Daynes R.A. Regulation of macrophage dehydroepiandrosterone sulfate metabolism by inflammatory cytokines. Endocrinology 135 1 (1994) 67-75
85. Gottfried-Blackmore A., Croft G., Clark J., McEwen B.S., Jellinck P.H., and Bulloch K. Characterization of a cerebellar granule progenitor cell line, EtC.1, and its responsiveness to 17-beta-estradiol. Brain Res. 186 1 (2007) 29-40
86. A. Sierra, A. Gottfried-Blackmore, T.A. Milner, B.S. McEwen, K. Bulloch, Steroid hormone receptor expression and function in microglia, Glia, doi:10.1002/glia.20644, Published Online: Feb 19, 2008.